Chandigarh

Financial BO

Goods

Medicines

Human Antihaemophillic Factor VIII High Purity1000IU

Government Medical College and Hospital

GMCH-32 | Chandigarh

Amount: Refer DocsCloses: 12 May 2021Closed

Timeline

Published20 Apr 2021
Closed12 May 2021
Technical Evaluation1 Jul 2021
Financial Evaluation2 Jul 2021
Award—

Bids

3 Bids2 Jul 2021

#	Company	Status
1	BAXALTA BIOSCIENCE INDIA PVT LTD Admitted-Finance	Admitted-Finance
2	Novo Nordisk India Private Limited Admitted-Finance 1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 \| BANGALORE \| BANGALORE \| KARNATAKA \| 560045	Admitted-Finance
3	GRIFOLS INDIA HEALTHCARE PRIVATE LIMITED Not Admitted-PreQual/Technical	Not Admitted-PreQual/Technical Not Complied with technical specification

Tender Value

Refer Docs

EMD Value

₹2.1 L

Closing Date

12 May 2021, 2:00 pmClosed

Tender Inviting Organisation

Name

Director Principal

Address

GMCH-32, Chandigarh

Work Description

Human Antihaemophillic Factor VIII High Purity 1000IU

Tender Information

Tender ID

2021_GMCH_59264_1

Reference Number

GMCH/PH-PRO/Med-528/2021

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Rate

Period of Work

40 days

Location

GMCH-32

Source Website

Subscribe to view

Eligibility / Pre-Qualification

As per tender document

Documents Required

12 documents required · 12 mandatory

Fee

RequiredEMD (.pdf)

PreQual/Technical

RequiredComplete specification with packing detail need to be mentioned by supplier. (.pdf)

RequiredManufacturing License from Principal Manufacturer. (.pdf)

RequiredGMP Certificate under Schedule M/revised Schedule M of Drug Cosmetic Act or WHOGMP from manufacturer (.pdf)

RequiredIf rates are quoted by the distributor/sister concern/ dealer then authority letter should be submit (.pdf)

RequiredAffidavit in prescribed performa regarding non-blacklisting of firm from Principal Manufacturer. (.pdf)

RequiredList of buyers to whom you have supplied drug (min 100 bedded hospitals) from Principal Manufacturer (.pdf)

RequiredNo.of yrs standing of firm in drug manufacturing sector(required min3yrs)from Principal manufacturer (.pdf)

RequiredUndertaking to be submitted that no mishap has been reported from any of item manufactured by firm. (.pdf)

RequiredAnnual turn over of min last 3 yrs duly certified by C.A. (min 1 crore) from Principal manufacturer. (.pdf)

RequiredValidity of rates and rate certificate. (.pdf)

Finance

RequiredPrice Bid (.xls)

Fee & Financial Details

Tender Fee Amount

₹0

EMD Fee Amount

₹2.1 L

Important Dates

Last Activity

2 Jul 2021

Published

20 Apr 2021

Bid Opening

13 May 2021

Download Starts

20 Apr 2021

Download Ends

12 May 2021

Submission Starts

20 Apr 2021

Stage Documents

Stage Summary Snapshot

stage.html

html • 0.03 MB

Technical Evaluation

tech_eval.pdf

PDF

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.03 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .

Loading…

Company

BAXALTA BIOSCIENCE INDIA PVT LTD

Admitted-Finance

Novo Nordisk India Private Limited

Admitted-Finance

1ST AND 2ND FLOOR NXT TOWER 2 EMBASSY MANYATA BUSINESS PARK NAGAVARA VILLAGE KASABA HOBLI BANGALORE KARNATAKA INDIA 560045 | BANGALORE | BANGALORE | KARNATAKA | 560045

GRIFOLS INDIA HEALTHCARE PRIVATE LIMITED

Not Admitted-PreQual/Technical